Supplementary Figure 3 from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial

L. Collet; Maude Ardin; David Venet; Justine Berthet; Sarah Barrin; Isabelle Treilleux; Jean‐Christophe Noël; Marianne Leheurteur; Jérôme Meunier; Leïla Bengrine-Lefèvre; Mathilde Martinez; Frank Priou; Frédèric Selle; Pierre-Alexandre Just; Guillaume Bataillon; Françoise Rothé; Christos Sotiriou; Christophe Caux; Bertrand Dubois; Isabelle Ray‐Coquard; Olivia Le Saux

doi:10.1158/1078-0432.29760202

Key Points

Tumor microenvironment influences overall survival outcomes in high-grade serous ovarian cancer.
PD-L1 expression levels correlate with survival rates across different treatment arms.
The analysis is based on data from a phase II randomized trial involving multiple tissue types.
Understanding PD-L1's role may guide future treatments and improve patient outcomes.

Implication

Randomized trial reveals associations between PD-L1 expression and overall survival in high-grade serous ovarian cancer, implying treatment implications.

Abstract

Supplementary Figure 3. Overall survival according to treatment arm and PD-L1 score.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Collet et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d021f https://doi.org/10.1158/1078-0432.29760202

View Full Paper

Ask AI

Bookmark

Share

Supplementary Figure 3 from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial

Key Points

Implication

Abstract

Discussion

Cite This Study

Supplementary Figure 3 from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading